Revelation Biosciences (REVB) Reports Q3 Loss of $0.42

Revelation Biosciences (NASDAQ: REVB) reported Q3 EPS of ($0.42).

For earnings history and earnings-related data on Revelation Biosciences (REVB) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Largo restructures $82.2M in debt, extending maturity to 2030
• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance